Sensitivity Of Pc9 And Cisplatin Resistant Pc9 Cell Lines To Cisplatin

Sensitivity of PC9 and cisplatin-resistant PC9 cell lines to cisplatin ...
Sensitivity of PC9 and cisplatin-resistant PC9 cell lines to cisplatin ...
Sensitivity of PC9 and cisplatin-resistant PC9 cell lines to cisplatin ...
Sensitivity of PC9 and cisplatin-resistant PC9 cell lines to cisplatin ...
Sensitivity of PC9 and cisplatin-resistant PC9 cell lines to cisplatin ...
Sensitivity of PC9 and cisplatin-resistant PC9 cell lines to cisplatin ...
Sensitivity of PC9 and cisplatin-resistant PC9 cell lines to cisplatin ...
Sensitivity of PC9 and cisplatin-resistant PC9 cell lines to cisplatin ...
Sensitivity of PC9 and cisplatin-resistant PC9 cell lines to cisplatin ...
Sensitivity of PC9 and cisplatin-resistant PC9 cell lines to cisplatin ...
a. Cisplatin sensitivity testing of A2780 and A2780cis cell lines ...
a. Cisplatin sensitivity testing of A2780 and A2780cis cell lines ...
Sensitivity to cisplatin of different ESCC cell lines at final ...
Sensitivity to cisplatin of different ESCC cell lines at final ...
Cisplatin sensitivity and NER capacity of human ovarian cancer cell ...
Cisplatin sensitivity and NER capacity of human ovarian cancer cell ...
Cisplatin sensitivity in a panel of TNBC cell lines as determined by ...
Cisplatin sensitivity in a panel of TNBC cell lines as determined by ...
Establishment and characterization of cisplatin resistant cell lines. A ...
Establishment and characterization of cisplatin resistant cell lines. A ...
Sensitization of cells to cisplatin is general among cell types and ...
Sensitization of cells to cisplatin is general among cell types and ...
Cisplatin sensitivity in a panel of TNBC cell lines as determined by ...
Cisplatin sensitivity in a panel of TNBC cell lines as determined by ...
Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell ...
Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell ...
Cell sensitivity to cisplatin increased upon co-treatment of cells with ...
Cell sensitivity to cisplatin increased upon co-treatment of cells with ...
Drug sensitivity to cisplatin and paclitaxel. Chemosensitivity of ...
Drug sensitivity to cisplatin and paclitaxel. Chemosensitivity of ...
The cisplatin sensitivity was enhanced in LSCC cell lines and tissues ...
The cisplatin sensitivity was enhanced in LSCC cell lines and tissues ...
Evaluation of cisplatin sensitivity in tumor cell lines injected into ...
Evaluation of cisplatin sensitivity in tumor cell lines injected into ...
Cell sensitivity to different doses of cisplatin upon pre-conditioning ...
Cell sensitivity to different doses of cisplatin upon pre-conditioning ...
Two day treatment of PC9, erlotinib resistant PC9 cells and normal ...
Two day treatment of PC9, erlotinib resistant PC9 cells and normal ...
Cell lines with acquired cisplatin resistance become more sensitive to ...
Cell lines with acquired cisplatin resistance become more sensitive to ...
Cisplatin resistance of lung cancer cell lines was assayed by MTT ...
Cisplatin resistance of lung cancer cell lines was assayed by MTT ...
Mutation and gene expression profiles of PC9 and resistant PC9GR cells ...
Mutation and gene expression profiles of PC9 and resistant PC9GR cells ...
Cell sensitivity to cisplatin alone or in combination with ALC ...
Cell sensitivity to cisplatin alone or in combination with ALC ...
Cell growth inhibition by cisplatin (A) A549, parental and resistant ...
Cell growth inhibition by cisplatin (A) A549, parental and resistant ...
Cisplatin sensitivity in NSCLC cells. (a) CCK-8 determination of cell ...
Cisplatin sensitivity in NSCLC cells. (a) CCK-8 determination of cell ...
Cisplatin sensitivity in NSCLC cells. (a) CCK-8 determination of cell ...
Cisplatin sensitivity in NSCLC cells. (a) CCK-8 determination of cell ...
Platinum sensitivity and non-cross-resistance of cisplatin analogue ...
Platinum sensitivity and non-cross-resistance of cisplatin analogue ...
Comparison of cisplatin sensitivity and the presence of sphere-forming ...
Comparison of cisplatin sensitivity and the presence of sphere-forming ...
| Differences in morphology and sensitivity to cisplatin between A549 ...
| Differences in morphology and sensitivity to cisplatin between A549 ...
NHE9 downregulates the CRT sensitivity of ESCC cell lines. Cisplatin ...
NHE9 downregulates the CRT sensitivity of ESCC cell lines. Cisplatin ...
Acquisition of Cisplatin Resistance Shifts Head and Neck Squamous Cell ...
Acquisition of Cisplatin Resistance Shifts Head and Neck Squamous Cell ...
Cisplatin resistance of CR-A549 and CR-PC9 cells. (A) After treatment ...
Cisplatin resistance of CR-A549 and CR-PC9 cells. (A) After treatment ...
Cisplatin resistance of CR-A549 and CR-PC9 cells. (A) After treatment ...
Cisplatin resistance of CR-A549 and CR-PC9 cells. (A) After treatment ...
MiR-26b partially reversed the cisplatin resistance of PC9/R and ...
MiR-26b partially reversed the cisplatin resistance of PC9/R and ...
MiR-199a-3p enhances cisplatin sensitivity of cholangiocarcinoma cells ...
MiR-199a-3p enhances cisplatin sensitivity of cholangiocarcinoma cells ...
Comparative Analysis of the Transcriptomic Response to Cisplatin in ...
Comparative Analysis of the Transcriptomic Response to Cisplatin in ...

Loading image details...

Source
Dimensions